Silverfin false false 31/12/2023 01/01/2023 31/12/2023 Dr Simon Dunlop 09/12/2022 30 August 2024 The principal activity of the company during the financial period was that of the provision of medical services. 14533507 2023-12-31 14533507 bus:Director1 2023-12-31 14533507 core:CurrentFinancialInstruments 2023-12-31 14533507 core:ShareCapital 2023-12-31 14533507 core:RetainedEarningsAccumulatedLosses 2023-12-31 14533507 bus:OrdinaryShareClass1 2023-12-31 14533507 2023-01-01 2023-12-31 14533507 bus:FilletedAccounts 2023-01-01 2023-12-31 14533507 bus:SmallEntities 2023-01-01 2023-12-31 14533507 bus:AuditExemptWithAccountantsReport 2023-01-01 2023-12-31 14533507 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 14533507 bus:Director1 2023-01-01 2023-12-31 14533507 bus:OrdinaryShareClass1 2023-01-01 2023-12-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 14533507 (England and Wales)

SIMON DUNLOP LIMITED

Unaudited Financial Statements
For the financial year ended 31 December 2023
Pages for filing with the registrar

SIMON DUNLOP LIMITED

Unaudited Financial Statements

For the financial year ended 31 December 2023

Contents

SIMON DUNLOP LIMITED

BALANCE SHEET

As at 31 December 2023
SIMON DUNLOP LIMITED

BALANCE SHEET (continued)

As at 31 December 2023
2023
£
Current assets
Debtors 3 14,304
Cash at bank and in hand 174,660
188,964
Creditors: amounts falling due within one year 4 ( 45,395)
Net current assets 143,569
Total assets less current liabilities 143,569
Net assets 143,569
Capital and reserves
Called-up share capital 5 1
Profit and loss account 143,568
Total shareholder's funds 143,569

For the financial year ending 31 December 2023 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of SIMON DUNLOP LIMITED (registered number: 14533507) were approved and authorised for issue by the Director on 30 August 2024. They were signed on its behalf by:

Dr Simon Dunlop
Director
SIMON DUNLOP LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2023
SIMON DUNLOP LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2023
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year, unless otherwise stated.

General information and basis of accounting

SIMON DUNLOP LIMITED (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Bridge House, Lydford, Okehampton, EX20 4BH, England, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Turnover

Turnover from the supply of services represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the fair value of the consideration received or receivable. Where payments are received from customers in advance of services provided, the amounts are recorded as deferred income and included as part of creditors due within one year.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets receivable within one year, such as trade debtors and bank balances, are measured at transaction price less any impairment.

Basic financial assets receivable within more than one year are measured at amortised cost less any impairment.

Financial assets are derecognised when and only when the contractual rights to the cash flows from the financial asset expire or are settled, or the Company transfers to another party substantially all of the risks and rewards of ownership of the financial asset, or the Company, despite having retained some, but not all, significant risks and rewards of ownership, has transferred control of the asset to another party.

Basic financial liabilities
Basic financial liabilities that have no stated interest rate and are payable within one year, such as trade creditors, are measured at transaction price.

Other basic financial liabilities are measured at amortised cost.

Financial liabilities are derecognised when the company’s contractual obligations expire or are discharged or cancelled.

2. Employees

2023
Number
Monthly average number of persons employed by the Company during the year, including the director 0

3. Debtors

2023
£
Trade debtors 1,800
Corporation tax 632
Other debtors 11,872
14,304

4. Creditors: amounts falling due within one year

2023
£
Taxation and social security 43,355
Other creditors 2,040
45,395

5. Called-up share capital

2023
£
Allotted, called-up and fully-paid
1 Ordinary share of £ 1.00 1

6. Related party transactions

Transactions with the entity's director

2023
£
Opening balance 0
Advances within the year 30,001
Advances repaid within the year (18,246)
Interest 117
Closing balance 11,872

The company had an outstanding directors loan in the name of Dr S Dunlop of £11,872 at the year end from advances made in the period. This loan carries interest in line with HMRC rates and is repayable on demand.